IntelGenx IGXT Stock
IntelGenx Price Chart
IntelGenx IGXT Financial and Trading Overview
| IntelGenx stock price | 0.19 USD |
| Previous Close | 0.21 USD |
| Open | 0.2 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.2 - 0.21 USD |
| 52 Week Range | 0.11 - 0.27 USD |
| Volume | 32.15K USD |
| Avg. Volume | 201.12K USD |
| Market Cap | 36.14M USD |
| Beta (5Y Monthly) | 2.437676 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IGXT Valuation Measures
| Enterprise Value | 46.28M USD |
| Trailing P/E | N/A |
| Forward P/E | 1.7243334 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 41.30028 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 52.888 |
| Enterprise Value/EBITDA | -5.172 |
Trading Information
IntelGenx Stock Price History
| Beta (5Y Monthly) | 2.437676 |
| 52-Week Change | 16.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.27 USD |
| 52 Week Low | 0.11 USD |
| 50-Day Moving Average | 0.17 USD |
| 200-Day Moving Average | 0.17 USD |
IGXT Share Statistics
| Avg. Volume (3 month) | 201.12K USD |
| Avg. Daily Volume (10-Days) | 99.63K USD |
| Shares Outstanding | 174.65M |
| Float | 130.2M |
| Short Ratio | N/A |
| % Held by Insiders | 23.16% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1111.086% |
| Gross Margin | -112.57% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.82% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 875K USD |
| Revenue Per Share (ttm) | 0.005 USD |
| Quarterly Revenue Growth (yoy) | -31.60% |
| Gross Profit (ttm) | -908000 USD |
| EBITDA | -8948000 USD |
| Net Income Avi to Common (ttm) | -10928000 USD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.84M USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 14.14M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.452 |
| Book Value Per Share (mrq) | -0.036 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9491000 USD |
| Levered Free Cash Flow (ttm) | -6115625 USD |
Profile of IntelGenx
| Country | United States |
| State | QC |
| City | Montreal |
| Address | 6420 Abrams |
| ZIP | H4S 1Y2 |
| Phone | 514-331-7440 |
| Website | https://www.intelgenx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was incorporated in 1999 and is headquartered in Montreal, Canada.
Q&A For IntelGenx Stock
What is a current IGXT stock price?
IntelGenx IGXT stock price today per share is 0.19 USD.
How to purchase IntelGenx stock?
You can buy IGXT shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IntelGenx?
The stock symbol or ticker of IntelGenx is IGXT.
Which industry does the IntelGenx company belong to?
The IntelGenx industry is Biotechnology.
How many shares does IntelGenx have in circulation?
The max supply of IntelGenx shares is 174.66M.
What is IntelGenx Price to Earnings Ratio (PE Ratio)?
IntelGenx PE Ratio is now.
What was IntelGenx earnings per share over the trailing 12 months (TTM)?
IntelGenx EPS is -0.06 USD over the trailing 12 months.
Which sector does the IntelGenx company belong to?
The IntelGenx sector is Healthcare.